Pharmacogenetic Testing Among Home Health Patients

Clinical trial NCT02378220 · COMPLETED

Trial details

NCT number: NCT02378220
Sponsor: Genelex Corporation
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Adverse Drug Events Adverse Drug Reactions Drug Interaction Potentiation Drug Metabolism, Poor, CYP2D6-RELATED Drug Metabolism, Poor, CYP2C19-RELATED Cytochrome P450 Enzyme Deficiency Cytochrome P450 CYP2D6 Enzyme Deficiency Cytochrome P450 CYP2C9 Enzyme Deficiency Cytochrome P450 CYP2C19 Enzyme Deficiency Cytochrome P450 CYP3A Enzyme Deficiency Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant

Start date: 2015-03-01
Primary completion: 2016-02-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.